A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy.

about

A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy.

Item

http://www.wikidata.org/entity/Q38640375

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

A novel CBCT-based method for ...... otactic ablative radiotherapy.

@en

type

Item

label

A novel CBCT-based method for ...... otactic ablative radiotherapy.

@en

prefLabel

A novel CBCT-based method for ...... otactic ablative radiotherapy.

@en

P1476

A novel CBCT-based method for ...... eotactic ablative radiotherapy

@en

P2093

Alan R Hounsell

http://www.w3.org/2001/XMLSchema#string

Ciara A Lyons

http://www.w3.org/2001/XMLSchema#string

Conor K McGarry

http://www.w3.org/2001/XMLSchema#string

Joe M O'Sullivan

http://www.w3.org/2001/XMLSchema#string

Raymond B King

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis of the alpha/beta ratio for prostate cancer in the presence of an overall time factor: bad news, good news, or no news?

A study of prostate delineation referenced against a gold standard created from the visible human data.

An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions

PTV margin definition in hypofractionated IGRT of localized prostate cancer using cone beam CT and orthogonal image pairs with fiducial markers.

Errors and margins in radiotherapy.

Evidence-based review of three-dimensional conformal radiotherapy for localized prostate cancer: an ASTRO outcomes initiative.

Pelvic nodal radiotherapy in patients with unfavorable intermediate and high-risk prostate cancer: evidence, rationale, and future directions.

Critical discussion of evaluation parameters for inter-observer variability in target definition for radiation therapy.

Stereotactic body radiotherapy for prostate cancer.

Optimal planning target volume margins for elective pelvic lymphatic radiotherapy in high-risk prostate cancer patients.

P2888

s13014-017-0859-z

P304

124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13014-017-0859-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stephen J. McMahon

Suneil Jain

Sarah O S Osman

P577

2017-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090990886

http://www.w3.org/2001/XMLSchema#string

P698

28778178

http://www.w3.org/2001/XMLSchema#string

P921

lymph node

P932

5543558

http://www.w3.org/2001/XMLSchema#string